Outset Medical (OM) Short term Debt (2019 - 2022)
Outset Medical (OM) reported Short term Debt of $1.0 million for Q2 2022, down 86.67% on a QoQ basis from $7.5 million in Q4 2019.
Outset Medical (OM) has 2 years of Short term Debt data on file, last reported at $1.0 million in Q2 2022.
- Quarterly Short term Debt changed N/A year-over-year to $1.0 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $1.0 million (changed N/A YoY) and the FY2019 annual result came in at $7.5 million, changed N/A from the prior year.
- Short term Debt declined to $1.0 million in Q2 2022 per OM's latest filing, from $7.5 million in the prior quarter.
- Across five years, Short term Debt topped out at $7.5 million in Q4 2019 and bottomed at $1.0 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Outset Medical | 90,946.35 | -286.55 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1.00 Mn |
| Dec 31, 2019 | 7.50 Mn |